PP121

SynDRA canonical compound SYN1950622 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	ABL1 \| EGFR \| HCK \| KDR \| MTOR \| PDGFRA \| PIK3CA \| PIK3CB \| PIK3CD \| PIK3CG \| PRKDC \| SRC
Mechanism of action	protein tyrosine kinase inhibitor

All known targets

ABL1
EGFR
HCK
KDR
MTOR
PDGFRA
PIK3CB
PIK3CG
PRKDC
SRC
PIK3CA
PIK3CD

Mechanisms of action (all sources)

tyrosine kinase inhibitor
PRKDC INHIBITOR
MTOR INHIBITOR
SRC INHIBITOR
KDR INHIBITOR
PIK3CG INHIBITOR
PDGFRA INHIBITOR
ABL1 INHIBITOR
HCK INHIBITOR
PIK3CB INHIBITOR
EGFR INHIBITOR

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

CCKBR

Cross-references

PubChem CID: 24905142
ChEBI: 50915
TTD: D03EHM

Synonyms

PP 121

Look up PP121 in the interactive SynDRA portal →